NANO Nuclear Energy Closes $400 Million Oversubscribed Private Placement of Common Stock with Preeminent Institutional Investors

Financing provides NANO Nuclear with financial flexibility and multiple years of operating runway in the race to develop the first advanced micro nuclear reactor in the U.S.
Financing raised at highest valuation to date; cash position is now approximately $600 million

New York, NY, Oct. 10, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company, today announced the closing of its previously announced private placement of common stock for gross

Primary participation in the private placement included an initial investment from preeminent asset managers alongside several new and existing institutional investors. In the private placement, NANO Nuclear sold 8,490,767 shares of common stock.

The financing provides NANO Nuclear with financial flexibility and multiple years of operating runway under its current plans, with cash on hand of approximately $600 million. These funds position NANO Nuclear as a leader in the race to build the first advanced nuclear micro reactor in the U.S.

NANO Nuclear will use its funding to advance development, construction and regulatory licensing activities for its lead micro reactor program, the KRONOS MMR Energy System, continue development of its other micro reactor projects and other nuclear energy supply chain related business lines, pursue potential strategic acquisitions, and for general corporate purposes.

“This financing is another significant milestone in our mission to build a fully integrated advanced nuclear energy company and reinforces our commitment to driving North America’s nuclear renaissance,” said Jay Yu, Founder and Chairman of NANO Nuclear. “New and continued support from some of the world’s leading institutional investors underscores their confidence in our technology, development progress, market position, and long-term vision. Our robust financial position provides us with multiple years of operational runway to advance our KRONOS MMR toward commercialization while maintaining the financial flexibility to pursue accretive opportunities that enhance our vertical integration and strengthen our market position. Our consistent ability to raise capital at higher valuations reflects both our disciplined execution and our commitment to delivering long-term shareholder value.”